Navigation Links
ALPHAGAN® 10 mL

ProductsALPHAGAN® 10 mL
Company Allergan, Inc.
Item ALPHAGAN® 10 mL
Features 
Description ALPHAGAN® (brimonidine tartrate ophthalmic solution) 0.2% is indicated for lowering IOP in patients with open-angle galucoma or ocular hypertension.
Info Allergan, Inc.
Customer Service: (714) 246-4500

Related medicine products :

1. ALPHAGAN® P 5 mL
2. ALPHAGAN® P 10 mL
3. ALPHAGAN® P 15 mL
4. ALPHAGAN® 5 mL
5. ALPHAGAN® 15 mL
Other Medicine News:Health News:Marshfield Clinic Selects SAP(R) BusinessObjects(TM) Solutions to Improve Patient Treatment and Clinic Management 2Health News:Marshfield Clinic Selects SAP(R) BusinessObjects(TM) Solutions to Improve Patient Treatment and Clinic Management 3Health News:Marshfield Clinic Selects SAP(R) BusinessObjects(TM) Solutions to Improve Patient Treatment and Clinic Management 4Health News:Marshfield Clinic Selects SAP(R) BusinessObjects(TM) Solutions to Improve Patient Treatment and Clinic Management 5Health News:Marshfield Clinic Selects SAP(R) BusinessObjects(TM) Solutions to Improve Patient Treatment and Clinic Management 6Health News:ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients 2Health News:ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients 3Health News:ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients 4Health News:ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients 5Health News:Sound Inpatient Physicians Expands to Long-Term Acute Care Facilities 2Health News:Marijuana Linked to Aggressive Testicular Cancer 2Health News:Marijuana Linked to Aggressive Testicular Cancer 3Health News:Marijuana Linked to Aggressive Testicular Cancer 4Health News:Cadient Group Continues Growth Trend with Key New Hires 2
Breaking Medicine Technology:PRA International Hosts an Infectious Diseases Audio Conference 2PRA International Hosts an Infectious Diseases Audio Conference 3ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 2ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 3Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3Osteotechs MagniFuse 28TM 29 Technology Used in First U S Surgery 5781 1Osteotechs MagniFuse 28TM 29 Technology Used in First U S Surgery 5781 2Osteotechs MagniFuse 28TM 29 Technology Used in First U S Surgery 5781 3Osteotechs MagniFuse 28TM 29 Technology Used in First U S Surgery 5781 4Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 1Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 2Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 3China Medical Technologies to Hold its Annual General Meeting on November 16 2009 5777 1China Medical Technologies to Hold its Annual General Meeting on November 16 2009 5777 2